cinnoline has been researched along with Obesity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bakhtyukov, AA; Derkach, KV; Kuznetsova, VS; Shpakov, AO; Sorokoumov, VN; Zakharova, IO | 1 |
Babushkina, AA; Bakhtyukov, AA; Balova, IA; Derkach, KV; Gureev, MA; Krasavin, M; Mikhaylov, VN; Novikov, AS; Shpakov, AO; Sorokoumov, VN; Zakharova, IO | 1 |
2 other study(ies) available for cinnoline and Obesity
Article | Year |
---|---|
[Characterization and biological activity of new 4-oxo-1,4-dihydrocinnoline-based inhibitors of the tyrosine phosphatase PTP1B and TCPTP].
Topics: Animals; Enzyme Inhibitors; Glucose; Insulin; Insulin Resistance; Leptin; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 2; Rats; Rats, Wistar; T-Lymphocytes; Tyrosine | 2022 |
Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(
Topics: Animals; Enzyme Inhibitors; Glucose; Insulin; Insulin Resistance; Male; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 2; Rats; Rats, Wistar; T-Lymphocytes | 2023 |